Among downregulated DEGs in Ubc9+/− Lgr5-EGFP+ cells, up to 17% were genes found to be repressed in early gastric cancer, colorectal adenocarcinoma, E2F1-overexpressing hepatocellular carcinoma and a subtype of basal breast cancer. This evidence concerns the gene UBE2I and breast cancer.